Navigation Links
Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin
Date:3/6/2013

d operations in the near term. We anticipate being able to provide more details in our upcoming 2012 fourth quarter and year-end update, when we will also discuss other Unigene initiatives and programs not affected by this development."

About Unigene Laboratories, Inc.
Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform.  Peptelligence™ encompasses extensive intellectual property covering drug delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence.  Core Peptelligence™ assets include proprietary oral and nasal peptide drug delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements, including statements relating to the assessment by the FDA of the recommendations of the Advisory Committee and that the FDA may or may not concur with the Advisory Committee's recommendations, and Unigene's ability to build a robust portfolio of proprietary partnerships in peptide-based therapeutics based on its Peptelligence™ platform. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These known and unknown risk factors include, but are not limited to: the delay in obtaining or the failure to obtain regulatory approvals for our products and the products of o
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Unigene to Announce Fourth Quarter and Full-Year 2011 Financial Results on March 8, 2012
2. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
3. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
4. Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011
5. A New way to Battle Acne? NPR says “Cut the Carbs”: Probiotic Action Comments on the Recent News
6. Probiotic Action Comments on New Findings on Using Light Therapy to Fight Acne
7. Acne Treatment Brand, Probiotic Action, Comments on the Use of a Virus to Treat Acne
8. Probiotic Comments on Claims that Plant-Based Oils Are the Best Acne Treatments
9. Probiotic Action Comments on Huffington Post’s, Best Foods for Acne and offers Advice on Foods to Balance your Body
10. An article from Bloomberg.com discusses Ban on a Common Acne Treatment; Probiotic Action Comments On the product Ban
11. Can You Be Too Old for Acne? Probiotic Action comments on news from The Vitals Blog
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 /PRNewswire-iReach/ -- Nanosyn, Inc. announced today ... Inc., to provide access to Nanosyn,s microfluidics screening ... platform for novel small molecule therapeutics. ... to work with FORMA Therapeutics to explore key ... homeostasis. FORMA Therapeutics, decision to work with us ...
(Date:7/29/2014)... 2014 TransVac Solutions, the trusted leader ... transport solutions for hospitals, will be exhibiting at booth ... Annual Conference & Technical Exhibition Aug. 3-6 in Chicago, ... for making hospitals cleaner, reducing infection risk and saving ... life cycle. Staff will be available at booth ...
(Date:7/29/2014)... 2014  Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... its investment in Green Chemistry and donated more than ... year, the Company announced Monday in its new ... World? The report comes in a ... a responsible corporate citizen, including recognition for the second ...
(Date:7/29/2014)... 29, 2014 G-CON Manufacturing Inc., the ... today announced a new leadership appointment designed to drive ... and abroad. , Maik Jornitz, Chief Operating Officer ... President charged with leading the pioneering company through its ... this stage of development and look forward to providing ...
Breaking Biology Technology:Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3G-CON Manufacturing, Inc. Announces Maik Jornitz as President 2
... May 22 Advance Nanotech, Inc., (OTC,Bulletin Board: AVNA), ... selected as one of four finalists for the 2008 ... for,innovation in engineering. HRH the Duke of Edinburgh will ... medal to the winner of this year,s,competition at the ...
... Inc. (Nasdaq and SWX: BMRN) will host a ... Thursday, June 5, 2008 from,7:30 a.m. to 11:30 ... New York City. Members,of BioMarin,s senior management team ... new information about advancements in the,research and development ...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today ... REOLYSIN(R) at the 40-litre,batch size to SAFC ... the successful scale-up from 20 litres to ... Yields at the 40-litre scale should ...
Cached Biology Technology:Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 2Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 3Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 4BioMarin to Host Research and Development Day June 5th 2Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) 2Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) 3
(Date:7/29/2014)... Maryland Schools of Dentistry (UM SOD) and Medicine ... received a five-year $10.7 million grant award from ... (NIAID) of the National Institutes of Health to ... diseases (STDs). The grant, which renews a previous ... new direction for the research by studying chlamydial ...
(Date:7/29/2014)... PARIS, 29 JULY 2014 With thirty days to ... for the FEBS-EMBO 2014 Conference are well underway. The ... Biochemical Societies (FEBS), EMBO, and the French Society for ... Saturday, 30 August to Thursday, 4 September at the ... 2014 Conference is the largest meeting for the life ...
(Date:7/29/2014)... 1 in 100,000 people characterized by a loss of ... unknown, a new study by a team of researchers at ... and other European institutions confirms for the first time that ... July in Nature Genetics , is an important step ... sphincter in the lower esophagus opens, allowing food to enter ...
Breaking Biology News(10 mins):University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4Counting down to FEBS-EMBO 2014 in Paris, France 2Mysterious esophagus disease is autoimmune after all 2
... with Sartorius Stedim Biotech (SSB) and Adolf Kühner AG ... 2009 , ,Monthey, 19. Mai 2009 / b3c ... contract manufacturing to the biopharmaceutical industry, expands its product ... bioreactor. OrbShake bioreactors rely on orbital shaking ...
... plants into a renewable, nonpolluting replacement for crude oil. ... convert plant biomass into a building block for plastics ... have successfully converted cellulose -- the most common plant ... in one step. The result builds upon ...
... recently awarded 13 grants totaling more than $191,000 ... Grant proposals were reviewed during SIR,s 34th Annual ... Foundation is proud to be able to contribute ... SIR Foundation grant program is designed to benefit ...
Cached Biology News:ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 2ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 3Plastic that grows on trees, part two 2Society of Interventional Radiology Foundation awards $191,000 in grants 2Society of Interventional Radiology Foundation awards $191,000 in grants 3